Compare SGU & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGU | VSTM |
|---|---|---|
| Founded | 1995 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 410.0M | 470.7M |
| IPO Year | 1997 | 2011 |
| Metric | SGU | VSTM |
|---|---|---|
| Price | $12.86 | $4.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 22.3K | ★ 2.2M |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.90% | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,784,418,000.00 | $30,914,000.00 |
| Revenue This Year | N/A | $282.64 |
| Revenue Next Year | N/A | $72.25 |
| P/E Ratio | $6.70 | ★ N/A |
| Revenue Growth | 1.04 | ★ 209.14 |
| 52 Week Low | $11.31 | $4.01 |
| 52 Week High | $13.53 | $11.25 |
| Indicator | SGU | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 50.63 | 36.30 |
| Support Level | $12.31 | N/A |
| Resistance Level | $12.99 | $6.79 |
| Average True Range (ATR) | 0.34 | 0.38 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 39.84 | 15.24 |
Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.